Laboratoire Cerba

What Laboratoire Cerba does

Laboratoire Cerba is a France-based specialized medical biology laboratory and the largest of its kind in Europe, founded in 1967 and now operating as a subsidiary of the Cerba HealthCare group. From a 17,000 m2 headquarters in Frepillon opened in 2024, the company runs more than 1,300 specialized tests across 12 medical disciplines including allergology, autoimmunity, cytogenetics, hematology, infectiology, oncology, pharmacology, and toxicology, supported by advanced analytical platforms such as Next Generation Sequencing, UHPLC/MSMS, and RapidFire chromatography. It employs 650+ specialized biologists and technicians and serves patients, healthcare professionals, hospitals, referring laboratories, and pharmaceutical and biotech companies across more than 50 countries.

The business operates three primary revenue streams. The core is specialty medical biology testing billed under the French NABM nomenclature or hors nomenclature on a unit-pricing basis, with tests ranging from ≈€25 for basic biochemistry to over €2,000 for advanced cancer predisposition panels. A second stream is clinical trial biology services delivered through the Cerba Advanced Pathology arm, which supports pharmaceutical, biotech, and IVD manufacturers with multi-year contracts, biological sample storage, and CAP-accredited analytical work for 100+ concurrent trials. A third stream is IVD regulatory support through Cerba Xpert, helping manufacturers run IVDR clinical performance studies.

Go-to-market is enterprise B2B, combining a direct sales force (domestic and export teams) with digital self-service through the My Cerba portal and Cerba Flash connected prescription solution. Demand generation is anchored on scientific authority via Cerba Live Sessions webinars, the Biomedically Yours podcast, and ANDPC-accredited training programs rather than paid marketing. Recent strategic emphasis is on international clinical trial expansion (anchored by the May 2026 CAP accreditation) and product-line expansion such as the NIMO TEST non-invasive fetal Rhesus D genotyping partnership with BEDIA Genomics.

Name

Laboratoire Cerba

Legal name

Laboratoire Cerba

Website

https://lab-cerba.com

Company type

Private

Founded year

1967

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Laboratoire Cerba is the largest European specialized medical biology laboratory, operating from France to offer 1,300+ advanced diagnostic tests across 12 specialties for patients, healthcare professionals, referring laboratories, and pharmaceutical and biotech clients in 50+ countries.

Ownership category

akta.pro rank

Product category

Specialized Medical Laboratory Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Medical and Diagnostic Laboratories (62151)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Reference & Esoteric Testing Laboratories (HLAFAMAJ)

akta.pro secondary industries

Clinical Research & Trial Central Laboratories (HLAFAMAL), Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB), Clinical Chemistry & Immunoassay Laboratories (HLAFAMAB), Microbiology & Infectious Disease Testing Laboratories (HLAFAMAD), Microbiology & Infectious Disease Testing (Trial Support) (HLAGAEAF)

Keywords

• Specialized medical biology
• Clinical pathology services
• Diagnostic laboratory testing
• Clinical trial biology
• Medical examination services

Headquarters

HQ city

Frépillon

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Medical Biology Testing Services: Core laboratory testing services for patients, healthcare professionals, and referring laboratories. Services covered under French health insurance (NABM nomenclature) and include specialized tests in allergology, autoimmunity, biochemistry, cytogenetics, hematology, infectiology, oncology, pharmacology, and toxicology.
2. Clinical Trial Biology Services: Specialized laboratory services supporting pharmaceutical companies, biotech firms, and IVD manufacturers in clinical development programs. Services include therapeutic monitoring, efficacy evaluation, and development of innovative diagnostic tests for clinical diagnosis.
3. Specialized Testing (Private Pay): Some tests are classified as hors nomenclature (outside standard nomenclature) and may be privately paid. Pricing varies by test complexity, ranging from €80 to over €2,000 for advanced genetic panels.

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels7 records

Core offering

Laboratoire Cerba is a specialized medical biology laboratory that performs over 1,300 specialized diagnostic tests and techniques across 12 medical specialty areas (allergology, autoimmunity, biochemistry, cytogenetics, genetics, hematology, infectiology, oncology, onco-hematology, pharmacology, toxicology, and clinical trial biology). The laboratory serves referring laboratories, healthcare professionals, and pharmaceutical/biotech companies through direct sales, international export teams, and the My Cerba digital portal.

Product overview

Laboratoire Cerba operates as a specialized medical biology laboratory offering a comprehensive portfolio of diagnostic services. The core offering consists of over 1300 medical examinations and techniques spanning multiple specialties including allergology, autoimmunity, biochemistry, cytogenetics, genetics, hematology, infectiology, oncology, pharmacology, and toxicology. The laboratory supports its service offering with digital platforms: My Cerba (customer portal for result access and catalog), Cerba Flash (connected prescription solution), and Customer Care tutorials. Educational and training services include Cerba Live Sessions (webinars), Biomedically Yours podcast, and ANDPC-accredited training programs. For the pharmaceutical industry, Cerba provides clinical trial biology services through Cerba Advanced Pathology and IVD support through Cerba Xpert.

Differentiator

Problem solved

Functional benefit

Brands

• My Cerba: Customer portal providing quick access to results, catalog, and services including real-time tracking and equipment ordering
• Biomedically Yours
• Cerba Live Sessions
• Cerba Research
• Cerba Xpert
• Cerba Flash

Products and services

• Test Catalog (1,300+ Specialized Examinations) Comprehensive catalog of over 1,300 specialized medical examinations and techniques covering allergology, autoimmunity, biochemistry, cytogenetics, genetics, hematology, infectiology, oncology, onco-hematology, pharmacology, toxicology, and clinical trial biology. Tests are performed for referring laboratories, hospitals, clinics, and prescribing physicians, with some reimbursed under French NABM nomenclature and others billed as hors nomenclature (€25-€2,427+ per test).
• Cerba Advanced Pathology - Clinical Trial Biology Services Specialized clinical trial biology services for pharmaceutical, biotechnology, and in vitro diagnostic companies. Supports 100+ concurrent clinical trials with robust pre-analytical, analytical, and biological sample storage capacities. Includes therapeutic monitoring, efficacy evaluation, and development of innovative diagnostic tests. CAP-accredited.
• Cerba Xpert - IVD Manufacturer Support Support service for in vitro diagnostic (IVD) manufacturers seeking IVDR CE marking. Provides access to biological sample collections, reference diagnostic technologies, and regulatory expertise for clinical performance studies and validation.
• NIMO TEST (Non-Invasive Fetal Rhesus D Genotyping) Non-invasive prenatal testing (NIPT-RHD) for fetal Rhesus D genotyping from a simple maternal blood sample. Fully automated, fast, and highly sensitive technology developed in partnership with BEDIA Genomics, supporting pregnant women with Rhesus D-negative blood types.
• My Cerba Customer Portal Digital customer portal providing real-time access to patient test results, test catalog browsing, equipment ordering, and sample tracking with real-time Projected Release Date (DPS) tracking. Available for laboratories, physicians, and healthcare professionals.
• Cerba Flash - Connected Prescription Solution Connected digital prescription solution that eliminates paper-based processes and simplifies pre-analytical tasks including exam registration, barcode scanning, label printing, document attachment, and traceability checking for laboratories.

Quantifiable outcome

• 98% participant satisfaction for training programs
• +3 more outcomes

Named customers5 records

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Four partnerships are on record, tiered core and minor.

• BEDIA GenomicscoreTechnology or Integration · 14 September 2025Partnership to implement the NIMO TEST (non-invasive fetal Rhesus D genotyping/NIPT-RHD) at Cerba Laboratory. The test enables non-invasive fetal Rhesus D genotyping from maternal blood sample using fully automated, fast, and highly sensitive technology. Represents a major advance in care for pregnant women with Rhesus D-negative blood types. Ramdane Mallek, Head of Cerba's genomics platform, leads implementation.
• Cerba ResearchcoreStrategic or Co-development PartnerCollaboration with Cerba Research, a Cerba Healthcare Group entity specializing in clinical trials present on five continents. Most clinical trial biology activity is conducted through this partnership, supporting international clinical development programs for pharmaceutical and biotech clients.
• Cerba XpertminorStrategic or Co-development PartnerSupport for IVD manufacturers in obtaining IVDR CE mark through clinical performance studies. Provides access to biological sample collections and regulatory expertise to help manufacturers complete clinical validation and achieve regulatory approval.
• Academic and Hospital Medical TeamsminorStrategic or Co-development PartnerPrivileged relationship with academics and hospital medical teams. Cerba's expert team participates in numerous research projects and publications in partnership with public and private institutions to advance medical biology.

Scale indicators10 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Synlab: One of Europe's largest medical diagnostics services providers, operating a network of clinical laboratories across Europe providing routine and specialty testing. Direct competitor in European specialty medical biology and patient referral services.
• LGC Group: UK-based life sciences measurement and testing company with capabilities in clinical diagnostics, genomics, and reference materials. Comparable in specialty analytical and clinical testing services for the pharma and clinical trial markets.
• Mayo Clinic Laboratories: US-based reference laboratory offering a broad specialty and esoteric test catalog to clients worldwide. Comparable as a reference lab serving physicians, hospitals, and pharma with a comparable menu of advanced diagnostics.
• Unilabs: European clinical laboratory operator offering specialty and routine diagnostics across multiple countries. Comparable in serving referring physicians, hospitals, and pharma clients with a similar mix of specialty and esoteric testing.

Broad incumbents

• Sonic Healthcare: Global medical diagnostics company operating pathology and clinical laboratory services across Australia, Europe, and the US. Comparable in specialized clinical pathology and laboratory medicine services.
• Eurofins Scientific: Global leader in bioanalytical testing with a substantial clinical diagnostics footprint. Larger and more diversified across food, environmental, and pharma testing, but directly competes in specialty clinical diagnostics and clinical trial central lab services.
• Labcorp: One of the world's largest clinical laboratory networks, with deep central lab capabilities for clinical trials and a comprehensive specialty testing menu. Directly comparable in clinical trial biology services and esoteric/reference testing.
• Quest Diagnostics: US-based global clinical laboratory leader offering routine and advanced diagnostics, including genetic and molecular testing. Comparable as a reference lab serving physicians, hospitals, and pharma sponsors.
• Charles River Laboratories: Global contract research organization providing preclinical and clinical laboratory services, including central lab and biomarker capabilities for clinical trials. Comparable in serving pharma/biotech sponsors with clinical trial biology services.

Emerging players

• INOVA Diagnostics: Specialized diagnostics company focused on autoimmune disease testing, part of Werfen. Comparable as a specialty diagnostics provider with overlapping expertise in autoimmunity and immunology, areas where Cerba is also a leader.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/playlist?list=PLNgv8QzGdy-gqq5fSonW7dAx9NiSC9EkM
• Facebookfacebook.com/Laboser-100069496862701
• LinkedInlinkedin.com/company/cerba

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Laboratoire Cerba